Bottlebrush prodrug provides a novel strategy for nanomedicine-mediated combination therapy of multiple myeloma

查看全文 作　　者：Haozhi [1]Xu;Shuang [1]Zhu;Zhanjun [1]Gu 机构地区：[1]Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety,Institute of High Energy Physics,Chinese Academy of Sciences,Beijing 100049,China 出　　处：《Science China Materials》索引2023年第66卷第7期,共2页 摘　　要：A method to enhance the limitation of synergistic chemodrugs based on nanomedicine delivering to tumors was proposed in a recent paper published in Nature Nanotechnology[1].This research not only improves current front-line combination therapies for multiple myeloma(MM),but also offers a novel design idea for nanomedicine of other diseases. 关 键 词：MYELOMA DRUGS therapy